Seoul
South Korea
2
2018-11-29
2
2021-06-08
These are the the leading inventors for applications assigned to CELLBION CO., LTD.:
CELLBION CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer
#2 | 2014-07-17 ✅ Patent 9,925,284 granted on 2018-03-27Nanoparticle coated with ligand introduced with long hydrophobic chain and method for preparing same
Also check out CELLBION CO., LTD's (Seoul, South Korea) applicant profile with 2 patent applications submitted.
142142 ⎘